NOB to invest BRL 138.6m over the next two years to implement center dedicated to cancer treatment in Salvador (BA)
NOB investirá BRL 138,6m nos próximos dois anos para implantação de centro dedicado ao tratamento de câncer em Salvador (BA)
Intel ID : 338134
|
||||
Relevant Documents
| Notice / Relevant Fact | 07 Jan 2022 | Oncoclinicas_FR_Salvador_2021.pdf | PT |
|
| Intel ID | 338134 | |
| Value | EUR 21,49m | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Núcleo de Oncologia da Bahia
(31 Dec 2020) |
Revenue: EUR 17,70m EBITDA: EUR 3,04m Exchange Rate:
|
|
| Date |
 |
|
| Country | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.05.11 Oncology 30 Healthcare / 30.05 Specialized Medicine |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.